yasuhito imai

Affiliation and department：
Research theme for competitive and other funds (4)：

2019 - 2022 Development of new therapeutoc strategy for high-risk chemotherapy-refractory neuroblastoma
2017 - 2022 Acute and medium- to long-term effects of Asian dust and air pollutants on allergies and biomarker search
2016 - 2019 Establishment of therapeutic strategy for advanced gastrointestinal cancer with targeted alpha therapy
2015 - 2019 A Model of Clinical Data Management based on CDISC for Academia

Papers (28)：

于佳, 今井康人, 野村章洋, 米田隆, 村山敏典. 日本国内での新型コロナウイルス感染症のパイロット観察研究における電子同意書の使用(Use of Electronic Consent Forms in an Observational Pilot Study of Coronavirus Disease in Japan). 薬理と治療. 2022. 50. Suppl.2. s154-s165
于佳, 今井康人, 野村章洋, 米田隆, 村山敏典. 日本国内での新型コロナウイルス感染症のパイロット観察研究における電子同意書の使用(Use of Electronic Consent Forms in an Observational Pilot Study of Coronavirus Disease in Japan). 薬理と治療. 2022. 50. Suppl.2. s154-s165
Hiroshi Wakabayashi, Anri Inaki, Kenichi Yoshimura, Toshinori Murayama, Yasuhito Imai, Tetsuya Higuchi, Megumi Jinguji, Tohru Shiga, Seigo Kinuya. Author Correction: A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma. Scientific Reports. 2022. 12. 1
Rie Kuroda, Hiroshi Wakabayashi, Raita Araki, Anri Inaki, Ryosei Nishimura, Yasuhiro Ikawa, Kenichi Yoshimura, Toshinori Murayama, Yasuhito Imai, Tatsuyoshi Funasaka, et al. Phase I/II clinical trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation. European Journal of Nuclear Medicine and Molecular Imaging. 2022. 49. 5. 1574-1583
今井康人, 杉本修治, 山崎章子, 大嶋三郎, 古川仭, 村山敏典, 金子周一. 人工知能(AI)によるHAT(Health Age Trust)システム構築における介護スタッフの業務効率化向上に関するアンケート調査研究. 日本未病学会雑誌. 2022. 28. 1. 31-42

ｍore...

MISC (12)：

Yoshio Sakai, Masao Honda, Shigeyuki Matsui, Osamu Komori, Toshinori Murayama, Tadami Fujiwara, Masaaki Mizuno, Yasuhito Imai, Kenichi Yoshimura, Alessandro Nasti, et al. Development of novel diagnostic system for pancreatic cancer, including early stages, measuring mRNA of whole blood cells (vol 110, pg 1364, 2019). CANCER SCIENCE. 2019. 110. 11. 3615-3615
堀川尚嗣, 長瀬克彦, 今井康人, 杉本修治, 村山敏典. 金沢大学附属病院の研究者主導臨床研究における重篤な有害事象報告の記載内容の現状と対応. 薬理と治療. 2019. 47. Suppl.1. s87-s93
Shizuko Takahara, Nanayo Aoki, Kenkei Hasatani, Yasuhito Imai, Toshinori Murayama. A model of a hybrid system for randomization on that day. Japanese Pharmacology and Therapeutics. 2017. 45. s124-s129
栗林義和, 村山敏典, 武田仁勇, 長瀬克彦, 今井康人, 吉村健一, 矢野聖二. 人を対象とする医学系研究におけるモニタリングに対する本学の取り組み. 臨床薬理. 2015. 46. Suppl. S181-S181
今井康人, 金子周一. 先端医療開発研究の中でCRCの果たすべき役割 (特集先端医療と病院). 病院. 2014. 73. 7. 545-550

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page